Stock Market

Dividend investors seek stocks with the highest yields, solid earnings and cash flow to support them. However, not all stocks that offer high dividends have the financial performance to sustain them, and they may have to cut the return. These three stocks offer higher-than-average yields but have warranted caution over the last quarter and coming
0 Comments
Indicating that growth stocks are in the initial stages of a hot comeback, the iShares Russell 2000 (NYSEARCA:IWM), whose movements are largely determined by growth stocks, is up nearly 5% year-to-date. Moreover, on March 20, the U.S. Federal Reserve’s Summary of Economic projections indicated that the central bank still intends to cut its benchmark rate
0 Comments
Will the demand for artificial intelligence personal computers explode in 2024 and 2025? And, will Dell Technologies (NYSE:DELL) stock generate massive revenue from AI-compatible PC sales? The market seems to think so, and they’ve already sent DELL stock soaring. Consequently, eager investors need to be cautious now. Before you make any judgments, be sure to
0 Comments
With spring right around the corner, homebuyers anticipate a busy season fueled by potential economic boosts, including anticipated interest rate cuts. People might also shift focus to house hunting, which almost every American looks forward to because prices might be more discounted at this time of the year. Real estate agents suggest Super Bowl weekend
0 Comments
Is Archer Aviation (NYSE:ACHR) in perfect financial condition right now? The answer is: definitely not. On the other hand, Archer Aviation can be forgiven for being a “work in progress.” When you see the progress that this flying-taxi specialist has made, you’ll surely want to hold ACHR stock this year.  Just to recap, Archer Aviation manufactures electric vertical takeoff
0 Comments
Few stock sectors offer soar-or-sink possibilities like biotechnology stocks do. If you’re in the market for an intriguing biotech pick and can manage high risk, take a look at Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)stock. Actinium Pharmaceuticals develops targeted radiotherapies for refractory cancer cases. By “refractory,” I mean that Actinium Pharmaceuticals focuses on helping patients meaningfully improve their
0 Comments
Snowflake (NYSE:SNOW), which specializes in software for cloud-based data warehousing, was recently overvalued. I tried to warn investors about Snowflake’s trailing price-to-earnings ratio and suggested that SNOW stock was vulnerable to a pullback. That pullback came to pass, but it’s still not the right time to take a share position. Sure, Snowflake as an artificial intelligence
0 Comments